Description
Dr. Phillip Scheinberg, Chair of the ASH Guideline Panel on Aplastic Anemia, shares insights into the new evidence based recommendations for the diagnosis and management of aplastic anemia. These guidelines support clinical decision making on immunosuppressive therapy, transplant considerations, and long term follow up, helping clinicians navigate this rare and life threatening condition. These guidelines address an important topic, and evidence based guidelines will contribute to better quality care for patients with this hematological condition. ASH guidelines are rigorous and incorporate diverse multidisciplinary perspectives including patient input throughout the development process.
Learn more: hematology.org/aplastic-anemia